{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:39:47Z","timestamp":1787755187238,"version":"build-2784847793"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Revision total joint arthroplasty (TJA) has a higher rate of periprosthetic joint infection (PJI) compared with primary TJA, possibly as the result of increased allogeneic blood transfusion. Tranexamic acid (TXA) is gaining popularity in revision TJA to minimize blood loss and the need for transfusion; however, its effect on PJI reduction has yet to be investigated. The hypothesis of this study was that the administration of TXA during revision arthroplasty is protective against subsequent PJI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A prospectively maintained institutional database was used to identify patients who underwent revision TJA for aseptic failure from 2009 to 2018 and had a minimum follow-up of 90 days. Patients who developed PJI following revision arthroplasty were identified. All patients with PJI met Musculoskeletal Infection Society (MSIS) criteria. A multivariate analysis was performed to identify variables independently associated with PJI after aseptic revision TJA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Overall, 1,731 patients who underwent aseptic revision were identified; of these patients, 83 (4.8%) developed PJI. Patients who received TXA had significantly lower rates (p = 0.029) of PJI postoperatively at 3.30% compared with those who did not receive TXA at 5.73%. After controlling for relevant confounding variables, TXA remained a significant independent factor that protected against PJI (odds ratio [OR], 0.47 [95% confidence interval (CI), 0.23 to 0.90]; p = 0.030). Female sex was also identified as a significant independent factor that protected against PJI (OR, 0.52 [95% CI, 0.30 to 0.88]; p = 0.016). However, preoperative anemia was independently associated with an increased risk of subsequent PJI (OR, 2.37 [95% CI, 1.34 to 4.16]; p = 0.003).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Based on this study conducted at a single institution, the use of TXA during aseptic revision arthroplasty was independently associated with a reduced risk of subsequent acute PJI after adjusting for multiple patient characteristics and surgical factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level III<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.19.00925","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T11:00:27Z","timestamp":1612177227000},"page":"1344-1350","source":"Crossref","is-referenced-by-count":42,"title":["Tranexamic Acid Reduces the Rate of Periprosthetic Joint Infection After Aseptic Revision Arthroplasty"],"prefix":"10.2106","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-3054","authenticated-orcid":false,"given":"Mitchell R.","family":"Klement","sequence":"first","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"},{"name":"Orthopaedic Associates of Wisconsin, Pewaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-8593","authenticated-orcid":false,"given":"Fortunato G.","family":"Padua","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0202-4850","authenticated-orcid":false,"given":"William T.","family":"Li","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8195-8170","authenticated-orcid":false,"given":"Max","family":"Detweiler","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-5870","authenticated-orcid":false,"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"issue":"4","key":"bib1-20230810","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am."},{"issue":"2","key":"bib2-20230810","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.arth.2019.09.013","article-title":"Highlighting the roles of anemia and aspirin in predicting ninety-day readmission following aseptic revision total joint arthroplasty","volume":"35","author":"Li","year":"2020","journal-title":"J Arthroplasty."},{"key":"bib3-20230810","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4137\/CMAMD.S10859","article-title":"Clinical and economic burden of revision knee arthroplasty","volume":"5","author":"Bhandari","year":"2012","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord."},{"issue":"8","key":"bib4-20230810","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s11999-010-1251-6","article-title":"Revision hip arthroplasty: infection is the most common cause of failure","volume":"468","author":"Jafari","year":"2010","journal-title":"Clin Orthop Relat Res."},{"issue":"8","key":"bib5-20230810","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s11999-010-1308-6","article-title":"Revision total knee arthroplasty infection: incidence and predictors","volume":"468","author":"Mortazavi","year":"2010","journal-title":"Clin Orthop Relat Res."},{"issue":"11","key":"bib6-20230810","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.arth.2015.05.029","article-title":"Perioperative complications and length of stay after revision total hip and knee arthroplasties: an analysis of the NSQIP database","volume":"30","author":"Liodakis","year":"2015","journal-title":"J Arthroplasty."},{"issue":"9S","key":"bib7-20230810","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/j.arth.2017.02.076","article-title":"Preoperative anemia independently predicts 30-day complications after aseptic and septic revision total joint arthroplasty","volume":"32","author":"Lu","year":"2017","journal-title":"J Arthroplasty."},{"issue":"1","key":"bib8-20230810","first-page":"68","article-title":"Effectiveness of tranexamic acid in revision total knee arthroplasty","volume":"78","author":"Aguilera","year":"2012","journal-title":"Acta Orthop Belg."},{"issue":"6","key":"bib9-20230810","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5301\/HIP.2012.10143","article-title":"The effect of bolus administration of tranexamic acid in revision hip arthroplasty","volume":"22","author":"Kazi","year":"2012","journal-title":"Hip Int."},{"issue":"2","key":"bib10-20230810","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11999-010-1441-2","article-title":"Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty","volume":"469","author":"Noordin","year":"2011","journal-title":"Clin Orthop Relat Res."},{"key":"bib11-20230810","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1874325001610010439","article-title":"Tranexamic acid in a multimodal blood loss prevention protocol to decrease blood loss in revision total knee arthroplasty: a cohort study","volume":"10","author":"Ortega-Andreu","year":"2016","journal-title":"Open Orthop J."},{"issue":"12","key":"bib12-20230810","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.arth.2016.05.058","article-title":"Tranexamic acid reduces blood transfusions in revision total hip arthroplasty","volume":"31","author":"Park","year":"2016","journal-title":"J Arthroplasty."},{"issue":"9","key":"bib13-20230810","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1302\/0301-620X.88B9.17605","article-title":"Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery?","volume":"88","author":"Phillips","year":"2006","journal-title":"J Bone Joint Surg Br."},{"issue":"9","key":"bib14-20230810","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.arth.2014.03.047","article-title":"Decreased blood transfusion following revision total knee arthroplasty using tranexamic acid","volume":"29","author":"Samujh","year":"2014","journal-title":"J Arthroplasty."},{"issue":"8","key":"bib15-20230810","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.arth.2013.05.036","article-title":"One dose of tranexamic acid is safe and effective in revision knee arthroplasty","volume":"28","author":"Smit","year":"2013","journal-title":"J Arthroplasty."},{"issue":"11","key":"bib16-20230810","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.arth.2016.03.059","article-title":"The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: a randomized, controlled trial","volume":"31","author":"Wu","year":"2016","journal-title":"J Arthroplasty."},{"issue":"2","key":"bib17-20230810","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5301\/hipint.5000324","article-title":"Transfusion of packed red blood cells stored >14 days was associated with a higher risk of infection after hip revision arthroplasty","volume":"26","author":"Tornero","year":"2016","journal-title":"Hip Int."},{"issue":"4","key":"bib18-20230810","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2106\/JBJS.L.01041","article-title":"Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty","volume":"96","author":"Newman","year":"2014","journal-title":"J Bone Joint Surg Am."},{"issue":"4","key":"bib19-20230810","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2106\/JBJS.L.01268","article-title":"Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty","volume":"96","author":"Friedman","year":"2014","journal-title":"J Bone Joint Surg Am."},{"issue":"9","key":"bib20-20230810","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.arth.2014.03.048","article-title":"Predictors and complications of blood transfusion in total hip and knee arthroplasty","volume":"29","author":"Frisch","year":"2014","journal-title":"J Arthroplasty."},{"issue":"9","key":"bib21-20230810","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.arth.2016.02.077","article-title":"Individualized risk model for venous thromboembolism after total joint arthroplasty","volume":"31","author":"Parvizi","year":"2016","journal-title":"J Arthroplasty."},{"issue":"10","key":"bib23-20230810","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s11999-012-2435-z","article-title":"Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection?","volume":"470","author":"Greenky","year":"2012","journal-title":"Clin Orthop Relat Res."},{"issue":"5","key":"bib24-20230810","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.arth.2014.12.026","article-title":"Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty","volume":"30","author":"Viola","year":"2015","journal-title":"J Arthroplasty."},{"issue":"18","key":"bib25-20230810","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.2106\/JBJS.M.01363","article-title":"Risk factors for surgical site infection following total joint arthroplasty","volume":"96","author":"Rasouli","year":"2014","journal-title":"J Bone Joint Surg Am."},{"issue":"11","key":"bib26-20230810","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1007\/s11999-017-5469-4","article-title":"What should define preoperative anemia in primary THA?","volume":"475","author":"Klement","year":"2017","journal-title":"Clin Orthop Relat Res."},{"issue":"4","key":"bib27-20230810","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1302\/0301-620X.98B4.36245","article-title":"The pre-operative levels of haemoglobin in the blood can be used to predict the risk of allogenic blood transfusion after total knee arthroplasty","volume":"98-B","author":"Maempel","year":"2016","journal-title":"Bone Joint J."},{"issue":"10","key":"bib28-20230810","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1007\/s00167-016-4183-1","article-title":"Preoperative haemoglobin cut-off values for the prediction of post-operative transfusion in total knee arthroplasty","volume":"24","author":"Yeh","year":"2016","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"issue":"4","key":"bib29-20230810","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2106\/JBJS.17.00237","article-title":"Perioperative allogeneic red blood-cell transfusion associated with surgical site infection after total hip and knee arthroplasty","volume":"100","author":"Everhart","year":"2018","journal-title":"J Bone Joint Surg Am."},{"issue":"5","key":"bib30-20230810","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood.V97.5.1180","article-title":"Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?","volume":"97","author":"Vamvakas","year":"2001","journal-title":"Blood."},{"issue":"23","key":"bib31-20230810","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2106\/JBJS.N.00077","article-title":"Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates","volume":"96","author":"Hart","year":"2014","journal-title":"J Bone Joint Surg Am."},{"issue":"10","key":"bib32-20230810","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.arth.2018.06.023","article-title":"The efficacy of tranexamic acid in total hip arthroplasty: a network meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty."},{"issue":"10","key":"bib33-20230810","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.arth.2018.04.043","article-title":"The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty."},{"issue":"1","key":"bib34-20230810","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11999-012-2488-z","article-title":"Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty","volume":"471","author":"Gillette","year":"2013","journal-title":"Clin Orthop Relat Res."},{"issue":"10","key":"bib35-20230810","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.arth.2018.03.031","article-title":"The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty."},{"issue":"9S","key":"bib36-20230810","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1016\/j.arth.2017.02.008","article-title":"Tranexamic acid was safe in arthroplasty patients with a history of venous thromboembolism: a matched outcome study","volume":"32","author":"Sabbag","year":"2017","journal-title":"J Arthroplasty."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.19.00925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:39:00Z","timestamp":1787751540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.19.00925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":35,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.19.00925","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]}}}